Cyclosporine vs. tacrolimus after liver transplantation for primary sclerosing cholangitis – a propensity score-matched intention-to-treat analysis

There is controversy regarding the optimal calcineurin inhibitor type after liver transplant(ation) (LT) for primary sclerosing cholangitis (PSC). We compared tacrolimus with cyclosporine in a propensity score-matched intention-to-treat analysis based on registries representing nearly all LTs in Eur...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of hepatology Ročník 80; číslo 1; s. 99 - 108
Hlavní autori:	Åberg, Fredrik, Sallinen, Ville, Tuominen, Samuli, Adam, René, Karam, Vincent, Mirza, Darius, Heneghan, Michael A., Line, Pål-Dag, Bennet, William, Ericzon, Bo-Göran, Grat, Michal, Lodge, Peter, Rasmussen, Allan, Schmelzle, Moritz, Thorburn, Douglas, Fondevila, Constantino, Helanterä, Ilkka, Nordin, Arno
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Netherlands Elsevier B.V 01.01.2024
Predmet:	Adult calcineurin inhibitor Calcineurin Inhibitors Cholangitis, Sclerosing - drug therapy Cholangitis, Sclerosing - etiology Cholangitis, Sclerosing - surgery Cyclosporine - therapeutic use Graft Rejection - drug therapy Graft Rejection - epidemiology Graft Rejection - prevention & control Graft Survival Humans Immunosuppressive Agents - therapeutic use Intention to Treat Analysis Liver Transplantation - adverse effects outcome Propensity Score PSC recurrence Retrospective Studies survival Tacrolimus - therapeutic use recurrence PSC calcineurin inhibitor outcome survival
ISSN:	0168-8278, 1600-0641, 1600-0641
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!